SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0002008861-24-000009
Filing Date
2024-08-29
Accepted
2024-08-29 08:48:02
Documents
126
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ndoi-20240630.htm   iXBRL 10-Q 3389746
2 EX-31.1 a20240630ex311ceo302cert.htm EX-31.1 8180
3 EX-31.2 a20240630ex312cfo302cert.htm EX-31.2 8216
4 EX-32.1 a20240630ex321ceo906cert.htm EX-32.1 6022
5 EX-32.2 a20240630ex322cfo906cert.htm EX-32.2 6051
  Complete submission text file 0002008861-24-000009.txt   18203653

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ndoi-20240630.xsd EX-101.SCH 121742
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ndoi-20240630_cal.xml EX-101.CAL 103036
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ndoi-20240630_def.xml EX-101.DEF 782563
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ndoi-20240630_lab.xml EX-101.LAB 1111598
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ndoi-20240630_pre.xml EX-101.PRE 973458
128 EXTRACTED XBRL INSTANCE DOCUMENT ndoi-20240630_htm.xml XML 3301887
Mailing Address 1400 ATWATER DRIVE MALVERN PA 19355
Business Address 1400 ATWATER DRIVE MALVERN PA 19355 (484) 216-0000
Endo, Inc. (Filer) CIK: 0002008861 (see all company filings)

IRS No.: 301390281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-280767 | Film No.: 241258948
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)